Panama Highest-Class Rule: DE 490 Article 30 in Practice

1. Key takeaways

Where the characteristics of a device allow it to fall into two risk classes at the same time, Panama requires the higher of the two to be taken. This is written expressly in Article 30, third paragraph of Decreto Ejecutivo N° 490, whose official wording provides that when a medical device can be classified simultaneously in two categories, the highest of the two shall be considered. The rule has no exception clause and does not bend to filing strategy. If the classification rationale leaves the question open, the company should prepare the file at the higher class before submission rather than wait for the DNDM to decide.

• The rule is unconditional and applies to every product type.
• The written argument matters as much as the conclusion, because the DNDM reads how the choice was made.
• One class step up raises both the document set and the review format, and the review format is the larger cost.
• A design change can reopen classification, and that chain is easy to miss in lifecycle management.

2. Legal basis

The rule sits inside a single article that also fixes what classification is based on and which rules apply. The surrounding articles then attach the consequences. The table keeps the whole chain together, because the practical effect of the highest-class rule is felt in Articles 31, 37 and 43 rather than in Article 30 itself.

3. Expert insights

Insight one: the highest-class rule makes the quality of the argument more important than the conclusion. The third paragraph of Article 30 fixes an outcome but says nothing about how the outcome is to be justified. What decides the review is whether the rationale covers the plausible alternative class and states why it was rejected. A file that says only that the product is class B, and a file that says the product falls in class A under one rule and in class B under another and is therefore taken as class B under Article 30, third paragraph, are two different documents in the eyes of the DNDM. The second makes the reasoning visible and, with it, the company’s compliance intent.

Insight two: the cost of moving up is paid twice, in documents and in review format. Under Article 37 the special requirements accumulate from A to D: class B must satisfy all class A requirements plus two more, class C adds two more again, and class D adds four. Under Article 31, classes C and D require at least two specialist physicians in the assessment while A and B leave that optional. Moving from B to C is therefore not a matter of two extra documents. It converts a review carried out by a single assessor into a panel assessment, and the schedule impact of that shift is larger than the document impact.

Insight three: a design change can retrigger classification, and the trigger chain is implicit. Article 43 lists design changes, including performance characteristics, operating principle and the specifications of materials, energy, software and accessories, among the substantial changes to a device. If the design changes, the risk profile may change, and the class may change with it. Lifecycle management tends to track whether the information printed on the certificate needs updating, and to overlook whether the class itself needs to be re-determined. When the class rises, both the special requirements and the review format have to be retrofitted, which is a textbook passive cost.

Insight four: the highest-class rule combines with the manufacturer declaration to produce a self-binding mechanism. The first paragraph of Article 30 bases classification on the manufacturer’s declaration, and the third paragraph requires the higher class where two apply. Read together, the two prevent a company from depressing the class by selective description. Article 33 of DE 490 then binds all submitted information to a sworn declaration, and the final sentence of that article provides for suspension or cancellation of the CCT or the operating licence where the declaration is not truthful. The rule is therefore backed by a sanction that reaches the licence itself, not merely the file.

4. Practical recommendations

• Write the classification rationale in three parts, rule, application and conclusion, and list the GHTF or IMDRF rule number relied on for each step.
• Where two classes are open, state both rules and the basis for taking the higher one explicitly. Do not leave the alternative unmentioned in the hope that the reviewer will not raise it.
• Estimate the schedule at the higher class, covering both document volume and review format, so that the project does not have to be re-planned mid-review.
• Add a mandatory decision point on whether classification must be re-determined to the design change procedure.
• Keep the class identical in the label, the instructions for use and the class field of the application form.

5. Verification checklist

• □ Record the official wording of the highest-class rule in Article 30, third paragraph of DE 490
• □ List every class the product could fall into, with the rule number for each
• □ Confirm the final class is the highest of those listed
• □ Check the special requirements for the final class against Article 37
• □ Confirm whether the specialist assessment under Article 31 is triggered
• □ Build a classification re-determination gate into the change management procedure (Article 43)

Regulatory information verified to 29 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Panamanian market. Our team manages Ministry of Health (MINSA) sanitary registrations through the DIGEMID-equivalent medical device directorate, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com